skip to main content
Idioma:
Mostrar Somente
Refinado por: Base de dados/Biblioteca: Oxford Journals remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
0503 EXERCISE PRACTICE IS INDEPENDENTLY ASSOCIATED WITH PERCEIVED SLEEP QUALITY, BUT NOT SLEEPINESS IN SEVERE OBSTRUCTIVE SLEEP APNEA PATIENTS
0503 EXERCISE PRACTICE IS INDEPENDENTLY ASSOCIATED WITH PERCEIVED SLEEP QUALITY, BUT NOT SLEEPINESS IN SEVERE OBSTRUCTIVE SLEEP APNEA PATIENTS
Material Type:
Artigo 		Adicionar ao Meu Espaço

0503 EXERCISE PRACTICE IS INDEPENDENTLY ASSOCIATED WITH PERCEIVED SLEEP QUALITY, BUT NOT SLEEPINESS IN SEVERE OBSTRUCTIVE SLEEP APNEA PATIENTS

da Silva, RP ; Piccin, CF ; Martins, EF ; Kaminski, RS ; Fischer, MK ; Zibetti, MR ; Giordani, JN ; Ramos, JM ; Oliveira, PG ; dos Santos, KC ; Rodrigues, LD ; Costa, LS ; da Silva, LM ; Bueno, KS ; Martinez, D

Sleep (New York, N.Y.), 2017-04, Vol.40 (suppl_1), p.A187-A187 [Periódico revisado por pares]

US: Oxford University Press

Texto completo disponível

Citações Citado por
2
0506 FALLING ASLEEP VERSUS FEELING SLEEPY IN SLEEP APNEA SCREENING
0506 FALLING ASLEEP VERSUS FEELING SLEEPY IN SLEEP APNEA SCREENING
Material Type:
Artigo 		Adicionar ao Meu Espaço

0506 FALLING ASLEEP VERSUS FEELING SLEEPY IN SLEEP APNEA SCREENING

Piccin, CF ; Martins, EF ; Kaminski, RS ; da Silva, RP ; Fischer, MK ; Zibetti, MR ; Ramos, JU ; Giordani, JN ; Oliveira, PG ; Lopes, BD ; Franciscatto, S ; de Almeida, EG ; dos Santos, GB ; Bueno, KS ; Martinez, D

Sleep (New York, N.Y.), 2017-04, Vol.40 (suppl_1), p.A188-A189 [Periódico revisado por pares]

US: Oxford University Press

Texto completo disponível

Citações Citado por
3
0789 Dedifferentiated fat cells: Potential involvement in intramuscular adipogenesis
0789 Dedifferentiated fat cells: Potential involvement in intramuscular adipogenesis
Material Type:
Artigo 		Adicionar ao Meu Espaço

0789 Dedifferentiated fat cells: Potential involvement in intramuscular adipogenesis

Duarte, M. S. ; Bueno, R. ; Dodson, M. V. ; Hausman, G. J.

Journal of animal science, 2016-10, Vol.94 (suppl_5), p.379-380 [Periódico revisado por pares]

Texto completo disponível

Citações Citado por
4
10 years follow up of the RASTER study; implementing a genomic signature in daily practice
10 years follow up of the RASTER study; implementing a genomic signature in daily practice
Material Type:
Artigo 		Adicionar ao Meu Espaço

10 years follow up of the RASTER study; implementing a genomic signature in daily practice

Vliek, S.B. ; Retel, V. ; Drukker, C. ; Rutgers, E. ; van Tinteren, H. ; van de Vijver, M.J. ; Bueno-De-Mesquita, J.M. ; Wesseling, J. ; van Harten, W. ; Linn, S.C.

Annals of oncology, 2017-09, Vol.28, p.v46-v46 [Periódico revisado por pares]

Elsevier Ltd

Texto completo disponível

Citações Citado por
5
1012P Resistance mechanisms to dual EGFR and MET inhibition in patients with EGFR-mutant MET-amplified non-small cell lung cancer
1012P Resistance mechanisms to dual EGFR and MET inhibition in patients with EGFR-mutant MET-amplified non-small cell lung cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

1012P Resistance mechanisms to dual EGFR and MET inhibition in patients with EGFR-mutant MET-amplified non-small cell lung cancer

Wang, K. ; Du, R. ; Roy, S. ; Vokes, N. ; Elamin, Y.Y. ; Bueno Hume, C. ; Skoulidis, F. ; Gay, C. ; Blumenschein, G. ; Fossella, F. ; Tsao, A. ; Lee, J.J. ; Rinsurongkawong, W. ; Rinsurongkawong, V. ; Gibbons, D. ; Vaporciyan, A. ; Zhang, J. ; Heymach, J. ; Altan, M. ; Le, X.

Annals of oncology, 2022-09, Vol.33, p.S1016 [Periódico revisado por pares]

Texto completo disponível

Citações Citado por
6
1201P The role of a mini tumour mutational burden (TMB) score generated with a customized NGS panel to predict benefit from immunotherapy
1201P The role of a mini tumour mutational burden (TMB) score generated with a customized NGS panel to predict benefit from immunotherapy
Material Type:
Artigo 		Adicionar ao Meu Espaço

1201P The role of a mini tumour mutational burden (TMB) score generated with a customized NGS panel to predict benefit from immunotherapy

Lombardi, P. ; Gambardella, V. ; Tarazona, N. ; Carbonell-Asins, J.A. ; Martín-Arana, J. ; Rentero-Garrido, P. ; Montón-Bueno, J.V. ; Gonzalez-Barrallo, I. ; Bruixola, G. ; Cejalvo, J.M. ; Martín-Martorell, P. ; Tébar-Martínez, R. ; Blesa, S. ; Seda, E. ; Pérez-Fidalgo, J.A. ; Insa Mollá, A. ; Fleitas, T. ; Zúñiga-Trejos, S. ; Cervantes, A. ; Roda, D.

Annals of oncology, 2020-09, Vol.31, p.S789-S789 [Periódico revisado por pares]

Elsevier Ltd

Texto completo disponível

Citações Citado por
7
1413PNeutrophil-platelet score (NPS), a predictive systemic inflammation score for PD-1 immune checkpoint inhibitors (ICI) in pretreated advanced non-small cell lung cancer (NSCLC) patients
1413PNeutrophil-platelet score (NPS), a predictive systemic inflammation score for PD-1 immune checkpoint inhibitors (ICI) in pretreated advanced non-small cell lung cancer (NSCLC) patients
Material Type:
Artigo 		Adicionar ao Meu Espaço

1413PNeutrophil-platelet score (NPS), a predictive systemic inflammation score for PD-1 immune checkpoint inhibitors (ICI) in pretreated advanced non-small cell lung cancer (NSCLC) patients

Mielgo Rubio, X ; Sereno Moyano, M ; Chara, L E ; López-Castro, R ; Rubio-Martínez, J ; Velastegui, A ; Olier-Garate, C ; Falagán, S ; Gómez-Barreda, I ; Riquelme, A ; Silva-Ruiz, J ; Moreno-Rubio, J ; López, C ; Bueno, C ; Cardeña, A ; Pérez-Fernández, E ; Martí-Castelló, M P ; Sotelo-Lezama, M J

Annals of oncology, 2018-10, Vol.29 (suppl_8) [Periódico revisado por pares]

Oxford University Press

Texto completo disponível

Citações Citado por
8
1439PD - BRCA1 expression level as prognostic factor for recurrence in resected NSCLC with adjuvant chemotherapy: SCAT Trial
1439PD - BRCA1 expression level as prognostic factor for recurrence in resected NSCLC with adjuvant chemotherapy: SCAT Trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

1439PD - BRCA1 expression level as prognostic factor for recurrence in resected NSCLC with adjuvant chemotherapy: SCAT Trial

Massuti Sureda, B. ; Sanchez Torres, J.M. ; Cobo Dols, M. ; Moran Bueno, M.T. ; Gonzalez-Larriba, J.L. ; Barneto Aranda, I.C. ; De Castro Carpeno, J. ; Iglesias, L. ; Muñoz, M.A. ; López Vivanco, G. ; Isla Casado, M.D. ; López, R. ; de las Penas Bataller, R. ; Rodriguez Abreu, D. ; Artal-Cortes, A. ; Esteban, E. ; Provencio, M. ; Pereira, E. ; Sanchez-Paya, J. ; Rosell, R.

Annals of oncology, 2019-10, Vol.30, p.v585-v585 [Periódico revisado por pares]

Elsevier Ltd

Texto completo disponível

Citações Citado por
9
1439PDBRCA1 expression level as prognostic factor for recurrence in resected NSCLC with adjuvant chemotherapy: SCAT Trial
1439PDBRCA1 expression level as prognostic factor for recurrence in resected NSCLC with adjuvant chemotherapy: SCAT Trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

1439PDBRCA1 expression level as prognostic factor for recurrence in resected NSCLC with adjuvant chemotherapy: SCAT Trial

Massuti Sureda, B ; Sanchez Torres, J M ; Cobo Dols, M ; Moran Bueno, M T ; Gonzalez-Larriba, J L ; Barneto Aranda, I C ; De Castro Carpeno, J ; Iglesias, L ; Muñoz, M A ; López Vivanco, G ; Isla Casado, M D ; López, R ; de las Penas Bataller, R ; Rodriguez Abreu, D ; Artal-Cortes, A ; Esteban, E ; Provencio, M ; Pereira, E ; Sanchez-Paya, J ; Rosell, R

Annals of oncology, 2019-10, Vol.30 (Supplement_5) [Periódico revisado por pares]

Oxford University Press

Texto completo disponível

Citações Citado por
10
1461P - NORA trial (GECP 15/02): Updated results of the Spanish Lung Cancer Group (SLCG) phase II trial of concurrent chemo-radiotherapy (CT-RT) with cisplatin (P) plus metronomic oral vinorelbine (mOV) for unresectable locally advanced non-small cell lung cancer (LA-NSCLC)
1461P - NORA trial (GECP 15/02): Updated results of the Spanish Lung Cancer Group (SLCG) phase II trial of concurrent chemo-radiotherapy (CT-RT) with cisplatin (P) plus metronomic oral vinorelbine (mOV) for unresectable locally advanced non-small cell lung cancer (LA-NSCLC)
Material Type:
Artigo 		Adicionar ao Meu Espaço

1461P - NORA trial (GECP 15/02): Updated results of the Spanish Lung Cancer Group (SLCG) phase II trial of concurrent chemo-radiotherapy (CT-RT) with cisplatin (P) plus metronomic oral vinorelbine (mOV) for unresectable locally advanced non-small cell lung cancer (LA-NSCLC)

Guirado, M. ; Majem, M. ; Massuti Sureda, B. ; de las Penas Bataller, R. ; Ortega Granados, A.L. ; Isla Casado, M.D. ; Domine Gomez, M. ; Marse Fabregat, R. ; Sala, M.A. ; Paredes Lario, A. ; Moran Bueno, M.T. ; Vazquez Estevez, S. ; Coves Sarto, J. ; Gonzalez-Larriba, J.L. ; Sanchez Torres, J.M. ; Vicente, D. ; Farre Bernado, N. ; Fernandez-Fornos, L. ; Varcarcel, F. ; Provencio, M.

Annals of oncology, 2019-10, Vol.30, p.v594-v594 [Periódico revisado por pares]

Elsevier Ltd

Texto completo disponível

Citações Citado por

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Revistas revisadas por pares (723)

Refinar Meus Resultados

Tipo de Recurso 

  1. Artigos  (723)
  2. Anais de Congresso  (2)
  3. Web Resources  (1)
  4. Outros  (1)
  5. Mais opções open sub menu

Data de Publicação 

De até
Refinar
  1. Antes de1984  (21)
  2. 1984Até1995  (28)
  3. 1996Até2005  (73)
  4. 2006Até2015  (320)
  5. Após 2015  (286)
  6. Mais opções open sub menu

Idioma 

  1. Inglês  (726)
  2. Japonês  (78)
  3. Russo  (4)
  4. Chinês  (1)
  5. Alemão  (1)
  6. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.